Home>
Stocks>
Decipher Labs Ltd

Decipher Labs Ltd (524752)

₹14.98▲0.33%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Decipher Labs Ltd share Performance

₹14.7
₹15
₹14.98
1.87%
Low
Day's Volatility:2.00%
High
0.13%
₹14.5
₹25.75
₹14.98
3.20%
Low
52 Weeks Volatility:75.10%
High
71.90%

Returns %
1 Month Return	-9.18 %
3 Month Return	-18.46 %
1 Year Return	-21.05 %

Market Stats
Previous Close	₹₹14.93
Open	₹₹15.00
Volume	₹15.70K
Upper Circuit	₹-
Lower Circuit	₹-
Market Cap	₹₹15.08Cr

Company Information

Combat Drugs CDL was incorporated as a private limited company in September 1986, and later converted into a public limited company in June 1992. It came out with an issue of 23.23 lac equity shares in November 1994 to finance the expansion of existing manufacturing facilities, especially for pharmaceutical formulations and sterile powder injectables. The company has developed in-house technology for dispersible and sustained release formulations and has also explored possibilities of exporting its products. It achieved major milestones in the years 1995-1996 and 1996-1997. In 1998-1999, the company extended operations into the IT sector, even proposing to change its name to Combat Drugs and IT Limited.

Share Price: ₹14.98 per share as on 17 May, 2024 04:01 PM
Market Capitalisation: ₹15.08Cr as of today
Revenue: ₹8.29Cr as on December 2023 (Q4 23)
Net Profit: ₹0.01Cr as on December 2023 (Q4 23)
Listing date: 01 Jan, 0001

Organisation	Decipher Labs Ltd
Headquarters	Ranga Reddy
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Fundamentals of Decipher Labs Ltd

Insights on Decipher Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 7.63 Cr → 8.29 Cr (in ₹), with an average increase of 8.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -1.94 Cr → 0.01 Cr (in ₹), with an average increase of 19500.0% per quarter
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 83.57% of holdings in Mar 2024 quarter
NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 94.5% return, outperforming this stock by 115.5%
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 123.6% return, outperforming this stock by 183.2%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 16.43% of holdings in Mar 2024 quarter
NEGATIVE IMPACT
Price Dip
In the last 1 year, Decipher Labs stock has moved down by -21.1%